IBD patients,
don't miss your Window of Opportunity.
Introducing PredictSURE IBD™ — the first validated prognostic test for Crohn's disease and ulcerative colitis.
PredictSURE IBD™
The first step towards personalized medicine in IBD
A whole blood test providing long-term prognostic data that can guide clinical management in Crohn’s disease and ulcerative colitis.
Features & Benefits
Questions & Answers
Order Collection Kits
Publications and Data
Healthcare Professionals
PredictSURE IBD™ is based upon 10 years of extensive research on gene expression profiling of CD8+ T cells. This whole blood-based biomarker test is a major step towards personalized medicine in IBD.
PredictSURE IBD™ is a biomarker test combined with a sophisticated, proprietary algorithm that will tell you the likely course of your newly diagnosed patients’ IBD; differentiating between an aggressive or milder form of the disease. All you need is a small blood sample from your patients (16+ years) and an on-line account for rapid, on-line reporting. With PredictSURE IBD™ you can further optimize and manger your patients' Crohn’s disease and ulcerative colitis.
